Senator Bill Cassidy's Medicare legislation protects fraudulent providers at seniors' expense
Source: Christopher Jacobs. "Bill Cassidy Defends Medicare Scammers Over America's Seniors." March 18, 2026. thefederalist.com
The Gist
The author argues that Senator Cassidy is trying to help Medicare scammers by proposing a law that would let companies overcharge for wound care products. This would cost seniors about $132 more per year in Medicare premiums, so Louisiana voters shouldn't reelect him.
Conclusion
Senator Bill Cassidy should not be reelected because his proposed legislation would perpetuate Medicare fraud in skin substitutes, costing seniors approximately $132 more per year in premiums
Premises
- Medicare spending on skin substitutes increased from $256 million in 2021 to $15.4 billion in 2025 due to systematic abuse by companies and doctors
- The Trump administration successfully implemented reforms that reduced skin substitute spending by 90% and saved seniors $11 per month in Medicare premiums
- Cassidy's proposed legislation would set reimbursement prices more than five times higher than the Trump administration's plan
- Cassidy's bill contains multiple provisions that would perpetuate fraud, including locking in inflated prices, discouraging rigorous FDA approval processes, and prohibiting CMS from determining clinical necessity
- Cassidy's bill would prevent manufacturers from reporting average sales prices, which leads to higher Medicare payments according to HHS inspector general recommendations
- Seniors pay approximately 25% of Medicare Part B costs through monthly premiums, so increased spending directly increases their financial burden
Assumptions
- The skin substitute industry constitutes systematic fraud rather than legitimate medical innovation
- The Trump administration's reforms were effective and appropriate
- Cassidy's motivations are to benefit fraudulent providers rather than improve patient care
- Electoral consequences are an appropriate remedy for policy disagreements
- Cost savings should be prioritized over potential access to medical treatments